Shingles in MS: A large retrospective study using Medicare and commercial claims found the recombinant zoster vaccine was about 64%–81% effective at preventing shingles in adults with multiple sclerosis, reinforcing vaccination value for immunology-heavy patients. Vaccine access gap: In New Zealand, a meningitis advocate says free meningococcal B vaccine eligibility for ages 13–25 is too narrow and should better reflect real risk, especially for Māori and Pasifika communities. Policy focus on care delays: A New Zealand health policy debate argues the system should prioritize waiting times and access measures (elective surgery, specialist visits, diagnostics, cancer care, ED turnaround, admissions, and discharge delays) over simply increasing spending. Pharmacy practice change: Nebraska lawmakers advanced LB955, allowing pharmacists to form practice agreements with physician assistants, with required notifications and periodic review. FDA inspections (food/biologics/devices): FDA posted mixed results from recent July inspections, including VAI findings for US Foods (Lexington County, SC) and Sturdiwheat Foods (Goodhue County, MN), NAI for International Nutraceuticals Group (Broward County, FL), and VAI for Hospitec USA (Sebastian County, AR). Health industry finance: Analysts moved targets on small-cap pharma—Canaccord raised Eton Pharmaceuticals to $68, while Maxim cut NeuroOne Medical to $5—highlighting how clinical and commercial execution can swing expectations fast. Care workforce & governance: Ghana’s health minister urged boards to stick to oversight and avoid day-to-day interference, aiming to strengthen governance in health institutions. Local health fundraising: Manitoulin Health Centre in Canada launched a matched campaign to raise $400,000 for critical medical equipment.